ArticleEMBO molecular medicine2026

Inhibition of PGC1β-dependent mitochondrial biogenesis enhances EGFR-targeted therapy in lung cancer.

Zhen Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.